Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study of Rapamycin for the Treatment of SLE

NCT00779194 is registered in ClinicalTrials.gov with State University of New York - Upstate Medical University as lead sponsor.

NCT NCT00779194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00779194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study of Rapamycin for the Treatment of SLE
Lead sponsor
State University of New York - Upstate Medical University
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
December 16, 2015
Enrollment
99 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus (sle)